Evidence map›Paper›PMID 22417984›Full record

ArticleAge and ageing2012

High-sensitivity C-reactive protein and mobility disability in older adults.

Joe Verghese, Roee Holtzer, Richard B Lipton, Cuiling Wang

Open access · bronzeAbstract read
In one paragraph

Article in Age and ageing, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Longitudinal Relationship Between Interleukin-6 and Perceived Fatigability Among Well-Functioning Adults in Mid-to-Late Life.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Article
  16. Article
  17. Article
  18. Association of Family History of Exceptional Longevity With Decline in Physical Function in Aging.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joe VergheseNeurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Einstein Aging Study, Bronx, NY 10461, USA. jverghes@aecom.yu.edu
Roee Holtzer
Richard B Lipton
Cuiling Wang
Albert Einstein College of Medicine · US

Funding

Vascular Structure and Function in Cognitive AgingP01AG003949 · NIA · YESHIVA UNIVERSITY · PI Richard B. LIPTON · 1985 to 2026
$73.9M
Latent Mobility Abnormalities And FrailtyR01AG025119 · NIA · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI VERGHESE, JOE · 2005 to 2009
$1.5M
NIA NIH HHS AG025119NIA NIH HHS AG03949NIA NIH HHS P01 AG003949
6 · The paper itself

Abstract

objectiveto determine the association of high sensitivity C-reactive protein (HsCRP) levels with a risk of mobility disability and decline in older adults with and without vascular disease.

designprospective cohort.

settingcommunity-residing population. SUBJECTS: six hundred and twenty-four adults age 70 and older (62% women) with gait and HsCRP assessments.

main outcome measuresincident mobility disability (velocity <70 cm/s) and annual rates of decline on gait velocity.

resultselevated HsCRP levels (≥ 3 mg/l) at baseline present in 224 of the 624 eligible subjects was associated with a faster annual decline in gait velocity of 0.91 cm/s (P=0.02). Subjects with elevated HsCRP levels had increased risk of mobility disability (hazard ratio: 1.85, 95% CI: 1.09-3.14). Each one-unit increase in log HsCRP levels in the 406 subjects without prevalent mobility disability was associated with increased risk of mobility disability (hazard ratio: 1.33, 95% CI: 1.05-1.68). The association of baseline HsCRP levels with mobility disability and decline was stronger in the 224 individuals without vascular disease. The associations were not significant in the 400 subjects with vascular disease.

conclusionsHsCRP levels predict mobility disability and accelerated decline in walking speed in older adults. These associations were stronger in those without vascular disease.

Indexed as

Disability EvaluationGeriatric AssessmentMobility LimitationAgedAged, 80 and overAge FactorsAgingBiomarkersC-Reactive ProteinFemaleGaitHumansInflammation MediatorsLinear ModelsMaleNew YorkBiomarkersC-Reactive ProteinInflammation Mediators

Identifiers

PMID22417984
PMCPMC3500856
OpenAlexW2096171091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.